Evidence map›Paper›PMID 37060173›Full record

ArticleCancer2023

Changing recommendations for lung cancer screening: National Lung Cancer Roundtable member perspectives.

Jan M Eberth, Michael R Gieske, Gerard A Silvestri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jan M EberthDepartment of Health Management and Policy, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-9500-4212
Michael R GieskeSaint Elizabeth Healthcare, Edgewood, Kentucky, USA.
Gerard A SilvestriSchool of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

Funding

Integrated data analysis of determinants of low-dose CT screening for lung cancerR21CA234295 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EBERTH, JAN MARIE · 2020 to 2020
$314k
NCI NIH HHS R21 CA234295
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung NeoplasmsEarly Detection of CancerHumansMass ScreeningSmokingTomography, X-Ray Computedcancer screeningcomputed tomography (CT)lung cancerUS Preventive Services Task Force

Identifiers

PMID37060173
PMCPMC10787349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.